Salinomycin exerts anti-colorectal cancer activity by targeting the β-catenin/T-cell factor complex.
Wang Z, Zhou L, Xiong Y, Yu S, Li H, Fan J, Li F, Su Z, Song J, Sun Q, Liu SS, Xia Y, Zhao L, Li S, Guo F, Huang P, Carson DA, Lu D.
Wang Z, et al. Among authors: carson da.
Br J Pharmacol. 2019 Sep;176(17):3390-3406. doi: 10.1111/bph.14770. Epub 2019 Jul 24.
Br J Pharmacol. 2019.
PMID: 31236922
Free PMC article.